title: [Mass spectrometry application for clinical diagnostics chairmen's introductory remarks].
abstract: Mass spectrometry has been recently used in clinical diagnostics, especially drug screening, newborn screening, and bacterial identification; therefore, the current developments in mass spectrometry platforms (i. e. GC-MS, LC-MS/MS) and applications for clinical diagnosis will be discussed. Technological advances in drug analyses and bacterial identification using mass spectrometry during recent years have provided an effective tool for the clinical laboratory. This symposium provides a comprehensive future overview of the latest technologies to quantify metabolites, drugs, and identify bacterial proteins using mass spectrometry, proposed for potential new biomarker development.
authors.affiliation: Human Health Sciences, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto 606-8507, Japan. saito.kuniaki.2w@kyoto-u.ac.jp
authors.forename: Kuniaki
authors.initials: K
authors.lastname: Saito
authors.forename: Fumio
authors.initials: F
authors.lastname: Nomura
mesh_terms: D001426:Bacterial Proteins / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D006801:Humans; D008403:Mass Screening / Q000379:methods; D013058:Mass Spectrometry / Q000295:instrumentation / Q000379:methods*
chemical_list: D001426:Bacterial Proteins; D015415:Biomarkers